| abstract |
A compound according to the present invention has a strong neuroprotective action and/or a neurorepair action, and therefore can serve as a therapeutic agent for neurological disorders (e.g., chronic inflammatory demyelinating polyneuritis, Guillain-Barre syndrome, periarteritis nodosa, allergic angiitis, diabetic peripheral neuropathy, entrapment syndrome, peripheral neuropathy associated with administration of chemotherapy medication, and peripheral neuropathy associated with Charcot-Marie-Tooth disease). Moreover, the crystals of the compound have excellent handling properties as a bulk drug substance. |